Neurontin (Gabapentin)

Gabapentin binds to the α2δ subunit of voltage‑gated calcium channels in the central nervous system. This binding limits calcium entry during nerve activation, which decreases the release of excitatory neurotransmitters and dampens neuronal hyperexcitability, thereby reducing seizure activity and pain transmission.

The appropriate dose of Neurontin is individualized by a qualified prescriber based on the patient’s condition, age, renal function and response to therapy. Dosage adjustments are made according to clinical judgment and monitoring, and no universal regimen is provided here.

Safety data for gabapentin in pregnancy and lactation are limited. The medication is classified as pregnancy category unknown, and clinicians must weigh potential benefits against possible risks. Breastfeeding mothers should discuss with their healthcare provider before using Neurontin.

To request Neurontin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both gabapentin (Neurontin) and pregabalin belong to the same class of calcium‑channel α2δ ligands and are used for neuropathic pain and seizures. Pregabalin generally has higher bioavailability and may require lower doses, while gabapentin is often less expensive but may need more frequent dosing. Clinical choice depends on efficacy, tolerability, cost and patient-specific factors.

Neurontin tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.

Neurontin is administered orally, typically as whole tablets that are swallowed with water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and any dose‑spacing with other medications.

Serious adverse reactions to Neurontin include severe skin reactions such as Stevens‑Johnson syndrome, suicidal thoughts or behaviors, respiratory depression especially when combined with other depressants, and rare hematologic abnormalities. Patients should seek immediate medical attention if they notice any of these symptoms.

Neurontin should be avoided in individuals with known hypersensitivity to gabapentin or any tablet excipients. Caution is advised for patients with severe renal impairment, uncontrolled depression, or a history of suicidal ideation. Pregnant or breastfeeding women should only use it under strict medical supervision.